Company Performance Metrics
Talisman Therapeutics Ltd is a human stem cell drug discovery company. We are committed to revolutionising the discovery of treatments for Alzheimer’s disease (AD). Our novel human stem cell models of AD provide a transformative platform for rapid and relevant compound identification, which significantly accelerate drug discovery. Talisman’s
primary goal is the exploitation of these systems to identify novel pharmacological treatments for Alzheimer’s disease initiation and progression through our in-house drug discovery programme. We also work with other organisations, on a collaborative basis, to maximise the impact of our own and their research and development activities. We collaborate with other organisations to assist with their drug discovery efforts. Partners include large pharmaceutical companies, small biotech businesses and universities.
